# Infectious Disease * **Definition:** Diseases caused by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi, that can be transmitted directly or indirectly from one individual to another. * **Taxonomy:** Specialties / Infectious Disease ## News * Selected news on the topic of **Infectious Disease**, for healthcare technology leaders * 17.5K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/20/2025 | [**North America Infectious Disease Rapid Diagnostics Market Report 2025-2035 ... - Yahoo Finance**](https://finance.yahoo.com/news/north-america-infectious-disease-rapid-082600474.html) | [[Yahoo Finance]] | | 5/20/2025 | [**Global Veterinary Infectious Disease Therapeutics Market Long-Term Vision, Strategic ...**](https://www.linkedin.com/pulse/global-veterinary-infectious-disease-therapeutics-market-long-term-zqdqf/) | [[Linkedin]] | | 4/28/2025 | [**Genomic sequencing-based detection system cuts infections and saves lives**](https://www.news-medical.net/news/20250428/Genomic-Sequencing-Based-Detection-System-Cuts-Infections-and-Saves-Lives.aspx) | [[News Medical Net]] | | 4/24/2025 | [**Molecular Diagnostics Market Set to Surge to USD 40.79 Billion by 2030, Driven by Technological Advancements and Rising Demand for Personalized Medicine**](http://prsync.com/maximize-market-research---mc/molecular-diagnostics-market-set-to-surge-to-usd--billion-by--driven-by-technological-advancements-and-rising-demand-for-persona-4726629/) | [[PRSync]] | | 4/17/2025 | [**Leaked Budget Document Confirms Axed CDC Offices**](https://www.medpagetoday.com/special-reports/features/115174) | [[Medpage Today]] | | 4/9/2025 | [**Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing ...**](https://www.prnewswire.com/news-releases/cepheid-and-oxford-nanopore-technologies-partner-to-advance-automated-sequencing-based-solutions-302424092.html) | [[PR Newswire]] | | 4/4/2025 | [**Molecular Diagnostic for Infectious Diseases Market Size to Reach $17.61 Billion by 2030 ...**](https://finance.yahoo.com/news/molecular-diagnostic-infectious-diseases-market-100900016.html) | [[Yahoo Finance]] | | 4/3/2025 | [**State and Local COVID-Era Funding Cuts Hit ID Hard - Medscape**](https://www.medscape.com/viewarticle/state-and-local-covid-era-funding-cuts-hit-id-hard-2025a100081v) | [[Medscape]] | | 3/26/2025 | [**Susan Monarez, Trump's CDC nominee, could be a good choice, if given the clout**](https://www.chiefhealthcareexecutive.com/view/susan-monarez-trump-s-cdc-nominee-could-be-a-good-choice-if-given-the-clout) | [[Chief Healthcare Executive]] | | 3/23/2025 | [**Avian Influenza: What Infectious Disease Physicians Need to Know**](https://www.medscape.com/viewarticle/avian-influenza-what-infectious-disease-physicians-need-know-2025a10006wd) | [[Medscape]] | | 3/11/2025 | [**Molecular Infectious Disease Testing Market Report 2025-2029 - Yahoo Finance**](https://finance.yahoo.com/news/molecular-infectious-disease-testing-market-121500112.html) | [[Yahoo Finance]] | | 3/6/2025 | [**The top 3 impacts of Trump's health data purge**](https://www.biopharmadive.com/news/top-3-impacts-trump-health-data-purge/741744/) | [[BioPharma Dive]] | | 3/5/2025 | [**Molecular Infectious Disease Testing Market to Hit US$17.78 Billion by 2029 with 13.7AGR - MarketsandMarkets™.**](https://www.globenewswire.com/news-release/2025/03/05/3037311/0/en/Molecular-Infectious-Disease-Testing-Market-to-Hit-US-17-78-Billion-by-2029-with-13-7-CAGR-MarketsandMarkets.html) | [[Globe Newswire]] | | 2/13/2025 | [**Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7AGR**](https://finance.yahoo.com/news/molecular-infectious-disease-testing-market-150500685.html) | [[Yahoo Finance]] | | 2/4/2025 | [**Global Real-time PCR Systems Market to Reach USD 13.7 Billion by 2035, with ... - Yahoo Finance**](https://finance.yahoo.com/news/global-real-time-pcr-systems-093000695.html) | [[Yahoo Finance]] | | 2/4/2025 | [**Dr. Tempe K. Chen from Miller Children's & Women's Hospital Receives Highest Honor in Pediatric Infectious Disease**](https://www.prnewswire.com/news-releases/dr-tempe-k-chen-from-miller-childrens--womens-hospital-receives-highest-honor-in-pediatric-infectious-disease-302367848.html) | [[PR Newswire]] | | 1/13/2025 | [**Switchboard, MD Announces ThreatAware: AI-Powered Support for Clinicians Addressing Emerging Health Threats**](https://www.prnewswire.com/news-releases/switchboard-md-announces-threataware-ai-powered-support-for-clinicians-addressing-emerging-health-threats-302349462.html) | [[PR Newswire]] | | 12/16/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827918) | [[JAMA Network]] | | 12/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2827395) | [[JAMA Network]] | | 11/19/2024 | [**Lindus Health Rolls Out All-in-One Infectious Disease CRO Bespoke to Clinical Trials for Infectious Disease Interventions**](https://www.prnewswire.com/news-releases/lindus-health-rolls-out-all-in-one-infectious-disease-cro-bespoke-to-clinical-trials-for-infectious-disease-interventions-302309386.html) | [[PR Newswire]] | | 11/19/2024 | [**Lindus Health Rolls Out "All-in-One Infectious Disease CRO" Bespoke to Clinical Trials for ...**](https://finance.yahoo.com/news/lindus-health-rolls-one-infectious-130700570.html) | [[Yahoo Finance]] | | 10/17/2024 | [**Health eCareers and the Pediatric Infectious Diseases Society Announce Partnership**](https://markets.businessinsider.com/news/stocks/health-ecareers-and-the-pediatric-infectious-diseases-society-announce-partnership-1033856294) | [[Business Insider Markets]] | | 9/20/2024 | [**Financing infectious disease services in hospitals: a common public good - The Lancet**](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00607-8/fulltext) | [[The Lancet]] | | 8/4/2024 | [**The infectious disease doctor shortage will hit marginalized people the hardest**](https://www.statnews.com/2024/08/05/infectious-disease-doctor-shortage-bio-preparedness-workforce-pilot-program/) | [[STAT]] | | 8/14/2023 | [**How to Become an Infectious Disease Doctor**](https://www.usnews.com/education/best-graduate-schools/top-medical-schools/articles/what-an-infectious-disease-doctor-is-and-how-to-become-one) | [[US News and World Report]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **National Foundation for Infectious Diseases (NFID)**: An organization dedicated to educating the public and healthcare professionals about infectious diseases. - **Innoviva, Inc.**: A company with a focus on critical care and infectious disease therapeutics, recognized for its treatment options for resistant infections. - **Switchboard, MD**: Developed ThreatAware, an AI-driven solution for early identification of infectious disease risks. - **MeMed**: A company utilizing machine learning for innovative diagnostic approaches in infectious diseases. - **Mayo Clinic**: A renowned medical center collaborating with Biotia to advance diagnostics in infectious diseases. - **Lindus Health**: A contract research organization (CRO) designed to expedite clinical trials for infectious diseases. - **GigaGen Inc.**: A biotechnology company developing recombinant polyclonal drugs for infectious diseases. - **Microbiologics**: A manufacturer specializing in reference materials for molecular diagnostics, particularly in infectious diseases. - **DCN Dx**: A leader in diagnostic development and clinical research services, focusing on advancing diagnostics for infectious diseases. - **Danaher**: A global science and technology innovator that provides diagnostic solutions, including molecular testing for infectious diseases. - **Abbott**: A healthcare company known for its diagnostic solutions, including tests for infectious diseases. - **National University of Singapore**: Launching a Master of Science program in Infectious Diseases Emergencies to prepare professionals for health crises. - **Merck**: A pharmaceutical company committed to addressing global health needs related to infectious diseases through vaccines and treatments. - **Roche**: A leader in healthcare that develops diagnostics and therapeutic solutions, including molecular diagnostics for infectious diseases. - **Precision BioSciences**: A biotechnology company focusing on gene editing for infectious diseases, particularly hepatitis. - **Biotia**: A precision medicine company specializing in AI-powered microbial analytics for infectious disease diagnostics. - **Delve Bio**: A company employing metagenomic sequencing to enhance detection and treatment of infectious diseases. - **Shionogi Inc.**: A pharmaceutical company focusing on infectious diseases, particularly known for its antibiotic Fetroja (cefiderocol). - **Thermo Fisher Scientific**: A major player in the life sciences sector, providing diagnostic tools and technologies for infectious disease detection. - **Africa Centres for Disease Control and Prevention**: An organization leveraging AI to improve outbreak detection and response capabilities in Africa. ### Partnerships and Collaborations - **Health eCareers and Pediatric Infectious Diseases Society**: A partnership to enhance job opportunities for pediatric infectious disease specialists. - **Merck and IDWeek**: Presentation of over 40 data presentations focusing on vaccines and treatments for infectious diseases. - **Biotia and Mayo Clinic**: Joint development agreement to enhance precision medicine in infectious disease diagnostics. - **University of Oxford**: Collaborated with global institutions to enhance AI applications in infectious disease research and response. - **KFSHRC and AI/Robotics**: KFSHRC integrates AI and robotics to improve diagnostic accuracy and surgical precision in infectious disease treatment. - **Climate Amplified Diseases and Epidemics (CLIMADE) consortium**: An international collaboration addressing climate-sensitive diseases and their implications for research and policy. - **Oxford Nanopore and Cepheid**: Collaboration to integrate sequencing technology with diagnostic systems for infectious diseases. - **Pfizer and BioNTech**: Collaboration on the development of COVID-19 vaccines, showcasing advancements in infectious disease management. - **SD Biosensor and Mongolia's NCCD**: Discussion on cooperation to combat infectious diseases in Mongolia. - **Shionogi and Qpex Biopharma**: Shionogi's acquisition of Qpex Biopharma aims to expand its infectious disease research operations in the U.S. - **Delve Bio and Broad Clinical Labs**: This partnership aims to enhance access to metagenomic sequencing for diagnosing neurological infections, improving the diagnostic process for infectious diseases. - **SpyBiotech and University of Oxford**: Collaboration to advance vaccine trials and development efforts in infectious diseases. - **VIC Tech and i-Seq Biotechnology**: VIC Tech supports i-Seq Biotechnology in developing innovative solutions for infectious disease prevention and treatment. - **DCN Dx and IDWeek**: Participation in IDWeek 2024 to showcase diagnostic development and clinical research services. - **Delve Bio and UCSF**: Partnership for the development of the Delve Detect platform, enhancing diagnostic accuracy for CNS infections. - **Biotia and medical institutions**: Collaborating to integrate the BIOTIA-ID test into clinical workflows to enhance accessibility for patients. - **Massachusetts Consortium on Pathogen Readiness**: A group of experts raising concerns about pandemic preparedness and advocating for improved surveillance. - **P95 BV and LatinaBA**: A strategic partnership aimed at enhancing vaccine and infectious disease research in Latin America, focusing on clinical and epidemiological trials. - **BioVaxys and RRPV**: Joining the Rapid Response Partnership Vehicle to accelerate the development of medical countermeasures for biological threats. ### Innovations, Trends, and Initiatives - **Climate Change Impact on Infectious Diseases**: Research indicating that climate change is expected to elevate the burden of infectious diseases. - **INVEST Pitch Perfect Event**: An event focusing on infectious diseases, highlighting the role of diagnostic and vaccine developers post-COVID-19. - **Podcast Guide for Infectious Diseases**: A peer-reviewed guide to credible audio podcasts aimed at combating misinformation in medical information dissemination. - **AI in Infectious Disease Management**: AI is being utilized to enhance disease detection, outbreak response, and healthcare accessibility, particularly in Africa. - **Molecular Infectious Disease Testing Market**: Projected growth from USD 9.37 billion in 2024 to USD 17.78 billion by 2029, driven by advancements in diagnostic technologies. - **ThreatAware**: An AI-powered tool that analyzes patient communications to identify infectious disease risks early. - **Microbiome Market Growth**: Increasing understanding of microbiomes leading to innovative therapies for infectious diseases. - **Spanish-language Resources by NFID**: Launch of a website to provide accessible information on infectious diseases for Spanish-speaking populations. - **Multiplex Molecular Assays**: Development of advanced testing options to improve diagnostic stewardship in infectious diseases. - **AI in Diagnostics**: Advancements in AI are enhancing research and response to infectious diseases, with potential applications in predicting outbreak trajectories and improving disease spread models. - **Point-of-Care Diagnostics**: Market expected to grow at a CAGR of 10.2%, enhancing accessibility and speed of infectious disease diagnostics. - **Innovative Diagnostics**: Companies like MeMed and Delve Bio are using machine learning and metagenomic sequencing to improve infectious disease diagnostics. - **Medical Clothing Innovations**: Growth in the medical clothing market driven by infection prevention awareness and advancements in antimicrobial fabrics. - **Multiplex Testing**: Integrated, fully automated multiplex diagnostic platforms are expected to transform the molecular infectious disease testing market by allowing simultaneous testing for multiple pathogens. - **Antimicrobial Resistance (AMR) Initiatives**: Shionogi is engaging the infectious disease community to combat AMR through educational initiatives and research. - **CRISPR Technology**: i-Seq Biotechnology is leveraging CRISPR interference technology to develop broad-spectrum vaccines against infectious diseases. - **Point-of-Care Diagnostics Market Growth**: Projected to grow significantly, driven by advancements in AI and lab-on-a-chip technologies, enhancing accessibility and efficiency in infectious disease testing. - **BEACON Platform**: An AI-driven surveillance system for emerging infectious diseases, enhancing global collaboration and response. ### Challenges and Concerns - **Resurgence of Infectious Diseases**: The rise of syphilis and other infectious diseases underscores the need for continued funding and research in infectious disease prevention. - **Financial Challenges in Infectious Disease Services**: Infectious disease clinical services face underfunding and lower reimbursement rates, complicating care for low-income patients. - **Occupational Exposure**: A study highlighted that infectious disease doctors had significantly higher infection rates during the COVID-19 pandemic, emphasizing the need for effective protective measures. - **Shortage of Infectious Disease Specialists**: A significant shortage persists, with nearly 80% of U.S. counties lacking an infectious disease physician, exacerbated by low compensation and limited residency program fill rates. - **Climate Change Impact**: Climate change is linked to the rise in infectious disease transmission, with projections indicating increased global disease burden due to environmental factors. - **Healthcare Accessibility**: Ensuring access to advanced diagnostic tools and treatments for infectious diseases remains a critical concern, particularly for vulnerable populations. - **Funding Allocation**: Concerns raised about the prioritization of chronic diseases over infectious diseases in federal funding, potentially impacting research and innovation. - **Healthcare Workforce Shortages**: Projected shortages of healthcare professionals, particularly in rural areas, exacerbating challenges in managing infectious diseases. - **Access to Federal Health Data**: Limitations on data access hindering the ability to address emerging infectious diseases effectively. - **Infrastructure in LMICs**: Inadequate infrastructure and investment hinder effective use of digital health tools for infectious disease diagnostics. - **Public Health Crises**: Ongoing crises, such as in Gaza, highlight the urgent need for medical aid and vaccination efforts amid rising infectious diseases. - **Antibiotic Resistance**: The rise in antibiotic-resistant infections necessitates ongoing research and monitoring, particularly in the context of doxycycline postexposure prophylaxis. - **Long COVID Research**: The ongoing study of long COVID emphasizes the need to understand the links between acute infections and chronic diseases. - **Antimicrobial Resistance**: The rise of antibiotic-resistant infections poses significant challenges for treatment and public health. - **Funding Cuts to Public Health**: Concerns about reduced funding impacting disease surveillance and outbreak response capabilities. - **Infection Prevention in ECMO Patients**: The need for standardized antimicrobial prophylaxis and infection prevention practices in patients receiving ECMO due to varying global practices. - **Antimicrobial Resistance (AMR)**: Need for improved diagnostic approaches to combat AMR effectively.